CRISPR, CAR-T, and NK: Current applications and future perspectives
Chimeric antigen receptor T (CAR-T) cell therapy represents a breakthrough in personalized cancer treatments. In this regard, synthetic receptors comprised of antigen recognition domains, signaling, and stimulatory domains are used to reprogram T-cells to target tum or cells and destroy them. Despit...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
KeAi Communications Co., Ltd.
2024-07-01
|
| Серія: | Genes and Diseases |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S235230422300404X |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|